Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Catching Up With George Stringer of Soraa at LFI 2018

One of the industry leaders to set up a booth at last week’s LightFair 2018 conference in Chicago, IL was Soraa. We stopped to speak with their Senior Vice-President of Sales and Marketing, George Stringer. “The nice thing about LightFair this year is that we were selected as one of the top ten booths to…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

One of the industry leaders to set up a booth at last week’s LightFair 2018 conference in Chicago, IL was Soraa. We stopped to speak with their Senior Vice-President of Sales and Marketing, George Stringer.

“The nice thing about LightFair this year is that we were selected as one of the top ten booths to see because of an award-winning product,” Stringer said. “People forget that we’re a technology company first. We’re a semiconductor company. We make violet based semiconductors in Freemont, California, because we believe that natural light should mirror what the sunlight does.”

For Soraa, there is an understanding that to meet their customers’ needs, the technology must be perfected before applications and products are even discussed. It is this dedication to the small details that has made them so popular with companies who crave the aesthetic provided by natural light.

“The people who care most about color quality would be museums, retail, high end, residential and hospitality. Those are the markets that we cater to,” Stringer said. “We’ve started focusing primarily on retail because that’s where light and color really matter.”

Stringer stopped to show us one of their cutting-edge designs, the Radiant GU10. It is a directional light that allows for proper lighting in spaces where display is essential.

“Museums are a critical vertical for us. If you think about what they’re trying to do in terms of color for the artwork and sculptures – if you’re going to have beautiful antiquities and art you want to light them with the best color quality of light,” he said. “I would say we’ve done close to 300 museums in North America alone,” Stringer noted.

Internationally, the company has a strong presence as well. Soraa’s products even light up the Palace of Versailles. Stringer believes much of this success is simply because they listen to what customers are asking for and find ways to make that a reality. When more lumens were required, they found a way to develop fixtures with more design freedom to incorporate heat sinks. And when it was discovered that violet light can be used to get rid of unwanted bacteria, the company began to develop innovative concepts using the technology they already had at their disposal.

“We found that we can increase the output of violet light to 405 nanometers and kill most of the bacteria in an eight-hour period,” Stringer said. “Violet has many purposes, it renders white, it gives better color, it gives a healthy light solution and it has medical applications for bacteria removal. We’re doing all of that for technology today, but also for products for the future.”

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The EU’s MDR delay buys time, but it won’t clear your commissioning bottleneck

The European Commission backed extending EU MDR transition deadlines to December 2027 and December 2028, Medical Design & Outsourcing reported. It buys time, not ramp-up capacity. Design News cites digital commissioning and machine digital twins to cut “power-on” surprises and speed validation and operator training.

  • 01If an EU portfolio includes Class III, December 2027 is now the planning anchor, but the internal gating item may shift to validation capacity and automation readiness, not paperwork.
  • 02Digital commissioning is becoming a procurement spec, not a buzzword, because it lets teams run DFM/DFA learning loops before hardware is built, which Design News notes is meant to reduce machine power-on surprises.

Sep 5, 2026

HCA’s Q1 was not about volume. It was about coverage and collecting cash

HCA Healthcare reaffirmed 2026 guidance after Q1 weather and a muted respiratory season cut adjusted EBITDA by about $180 million, according to HealthLeaders and Fierce Healthcare. Payer mix shifted fast. Exchange admissions fell about 15% and uninsured admissions rose about 16%, Fierce reported.

  • 01A mild flu season can be a margin event: HCA tied a 42% drop in respiratory admissions to a roughly $180M adjusted EBITDA hit (HealthLeaders, Fierce Healthcare).
  • 02The 2026 risk is sliding from demand to coverage: HCA cited a $600M–$900M full-year EBITDA headwind from exchange-related changes, with $150M already in Q1 (HealthLeaders, Fierce Healthcare).
  • 03Supplemental payments are becoming an operating capability, not a windfall: HCA said Q1 Medicaid program net benefit was about $200M vs $80M expected (HealthLeaders, Fierce Healthcare), putting state-by-state reimbursement strategy on the CFO’s critical path.

Sep 5, 2026

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits are turning into multi-year projects, not last-year decisions

Associate-led dental practice successions can take 3–5+ years. Dental Economics says associate-to-buyout timelines often run three to five-plus years. That pushes revenue-cycle controls, buy-sell terms, and tax structure earlier, before a buyer appears.

  • 01A practical benchmark is emerging for succession: bringing in an associate with intent to buy can take a minimum of three years and often more than five, according to Dental Economics.
  • 02If accounts receivable looks “high,” it may be a bookkeeping and posting problem before it is a payer problem, a revenue-cycle diagnostic Group Dentistry Now says shows up frequently at scale.
  • 03Exit planning is now an operating system project: valuation, tax positioning, and transition support belong in the same workstream, because deal structure can lock in or foreclose tax options, per Dental Economics.

Sep 4, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512